On August 21, TG Therapeutics rose 9.39% in regular trading, trading at $55.29 USD/share, with Turnover of $149 million.
Within the Biotechnology sector where TG Therapeutics belongs, the overall sector showed strength. Among individual stocks, Moderna up 10.95%, AbbVie up 1.46%, Amgen up 1.72%, Regeneron Pharmaceuticals up 1.89%, Gilead Sciences up 2.65%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)